| 2.44 Data as of May 24 |  -0.06 / -2.40%Today’s Change | 2.14 Today|||52-Week Range 4.77 | -13.78% Year-to-Date |
| Previous close | 2.50 |
| Today’s open | 2.49 |
| Day’s range | 2.42 - 2.53 |
| Volume | 500,058 |
| Average volume (3 months) | 1,375,461 |
| Market cap | $291.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -96.53% |
| Earnings growth (this year) | +15.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -86.83% |
| P/E ratio | NM |
| Price/Sales | 3,560.41 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ACRXAcelRx Pharmaceutica... | +0.41 | +5.50% |
| SNSSSunesis Pharmaceutic... | +0.04 | +0.72% |
| VICLVical Inc | -0.08 | -2.23% |
| RPRXRepros Therapeutics ... | +0.68 | +4.30% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $78.7K |
| Annual profit (last year) | -$29.2M |
| Net profit margin | -37,030.66% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer Mark Jerome Pykett, PhD, MBA |
President & Chief Business Officer Thomas H. Tulip, PhD |
Corporate headquarters Dublin, Ohio |
.
